Eritadenine: Difference between revisions
| Line 27: | Line 27: | ||
==Synthesis== |
==Synthesis== |
||
The structure is a purine alkylated with an oxidized sugar fragment. |
The structure is a purine alkylated with an oxidized sugar fragment. |
||
[[File:Eritadenine synthesis.svg|thumb|center| |
[[File:Eritadenine synthesis.svg|thumb|center|700px|Eritadenine synthesis:<ref>{{Cite doi|10.1016/S0040-4039(01)88795-5}}</ref> Alternative synthesis:<ref>{{Cite DOI|10.1002/jhet.5570090230}}</ref>]] |
||
Ring opening of the protected lactone ('''1'''), derived from [[erythrose]] with [[sodium phthalimide]] gives the acid '''2'''; hydrazinolysis (cf [[Gabriel synthesis]]) then leads to the amino acid '''3'''. Displacement of chlorine in [[pyrimidine]] '''4''' by the amine function on '''3''' serves to attach the future imidazole nitrogen and the sugar-derived sidechain ('''5'''). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with [[formic acid]]. These strongly acidic conditions serve to remove the acetonide protecting group as well ('''6'''). |
Ring opening of the protected lactone ('''1'''), derived from [[erythrose]] with [[sodium phthalimide]] gives the acid '''2'''; hydrazinolysis (cf [[Gabriel synthesis]]) then leads to the amino acid '''3'''. Displacement of chlorine in [[pyrimidine]] '''4''' by the amine function on '''3''' serves to attach the future imidazole nitrogen and the sugar-derived sidechain ('''5'''). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with [[formic acid]]. These strongly acidic conditions serve to remove the acetonide protecting group as well ('''6'''). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine ('''7''') |
||
==External links== |
==External links== |
||
Revision as of 05:49, 4 July 2015
| |
| Identifiers | |
|---|---|
| ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Eritadenine is an isolate of Shiitake. Eritadenine is an inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH) and has hypocholesterolemic activity.
Synthesis
The structure is a purine alkylated with an oxidized sugar fragment.
Ring opening of the protected lactone (1), derived from erythrose with sodium phthalimide gives the acid 2; hydrazinolysis (cf Gabriel synthesis) then leads to the amino acid 3. Displacement of chlorine in pyrimidine 4 by the amine function on 3 serves to attach the future imidazole nitrogen and the sugar-derived sidechain (5). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with formic acid. These strongly acidic conditions serve to remove the acetonide protecting group as well (6). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine (7)
External links
 | This organic chemistry article is a stub. You can help Wikipedia by expanding it. |
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/S0040-4039(01)88795-5, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/S0040-4039(01)88795-5instead. - ^ Template:Cite DOI